Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 12 results.
User Information
Export Records
  1. 1.   New complex polycyclic compounds: Synthesis, antiproliferative activity and mechanism of action
  2. Daidone, Giuseppe; D'Anneo, Antonella; Raimondi, Maria Valeria; Raffa, Demetrio; Hamel,Ernest; Plescia, Fabiana; Lauricella, Marianna; Maggio, Benedetta
  3. Bioorganic chemistry. 2020, AUG; 101: pii: 103989.
  1. 2.   Oxime Ether Lipids as Transfection Agents: Assembly and Complexation with siRNA.
  2. Puri, Anu; Zampino, Serena; Viard, Mathias; Shapiro, Bruce
  3. Methods in molecular biology (Clifton, N.J.). 2017 1632: 241-253.
  1. 3.   A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer
  2. Burger, A. M.; Gao, Y. G.; Amemiya, Y.; Kahn, H. J.; Kitching, R.; Yang, Y. L.; Sun, P.; Narod, S. A.; Hanna, W. M.; Seth, A. K.
  3. Cancer Research. 2005, NOV 15; 65(22): 10401-10412.
  1. 4.   Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKC delta-dependent increase in p27(Kip1) and decrease in retinoblastoma protein (pRb) phosphorylation
  2. Vucenik, I.; Ramakrishna, G.; Tantivejkul, K.; Anderson, L. M.; Ramljak, D.
  3. Breast Cancer Research and Treatment. 2005, MAY; 91(1): 35-45.
  1. 5.   Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells
  2. Sun, R. H.; Gao, P.; Chen, L.; Ma, D. L.; Wang, J. M.; Oppenheim, J. J.; Zhang, N.
  3. Cancer Research. 2005, FEB 15; 65(4): 1433-1441.
  1. 6.   The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-kappa B activity in drug-sensitive MCF-7 cells
  2. Brantley, E.; Patel, V.; Stinson, S. F.; Trapani, V.; Hose, C. D.; Ciolino, H. P.; Yeh, G. C.; Gutkind, J. S.; Sausville, E. A.; Loaiza-Perez, A. I.
  3. Anti-Cancer Drugs. 2005, FEB; 16(2): 137-143.
  1. 7.   Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity
  2. Jansen, A. P.; Camalier, C. E.; Stark, C.; Colburn, N. H.
  3. Molecular Cancer Therapeutics. 2004 3(2): 103-110.
  1. 8.   Aryl hydrocarbon receptor activation of an antitumor aminoflavone: Basis of selective toxicity for MCF-7 breast tumor cells
  2. Loaiza-Perez, A. I.; Kenney, S.; Boswell, J.; Hollingshead, M.; Alley, M. C.; Hose, C.; Ciolino, H. P.; Yeh, G. C.; Trepel, J. B.; Vistica, D. T.; Sausville, E. A.
  3. Molecular Cancer Therapeutics. 2004 3(6): 715-725.
  1. 9.   Anti-tumor2-(4-Aminophenyl)-5-fluoro-benzothiazole (5F203, NSC 703786) induces single-strand breaks and DNA-protein cross- links in sensitive MCF-7 breast cancer cells
  2. Brantley, E.; Stinson, S.; Kohlhagen, G.; Antony, S.; Sausville, E.; Pommier, Y.
  3. Clinical Cancer Research. 2003 9(16): 6075S-6075S.
  1. 10.   Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells
  2. Firon, M.; Shaharabany, M.; Altstock, R. T.; Horev, J.; Abramovici, A.; Resau, J. H.; Vande Woude, G. F.,; Tsarfaty, I.
  3. Oncogene. 2000 19(20): 2386-2397.
  1. 11.   Prolidase in Human Breast Cancer Mcf-7 Cells
  2. Palka, J. A.; Phang, J. M.
  3. Cancer Letters. 1998 127(1-2): 63-70.
  1. 12.   Cellular Delivery of siRNAs Using Bolaamphiphiles.
  2. Gupta, Kshitij
  3. Methods in molecular biology (Clifton, N.J.). 2017 1632: 187-205.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel